Crucell Announces PER.C6® Licensing Agreement with Pfizer Animal Health
Crucell N.V. and Pfizer Animal Health announced the signing of a research license agreement for PER.C6®. The license agreement allows Pfizer Animal Health to use Crucell's PER.C6® cell technology in the production of a non-disclosed veterinary vaccine. Pfizer Animal Health has an option to convert the research license into a commercial agreement. Financial details were not disclosed.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.